Malaria in children;La malaria nel bambino

Rivista Italiana di Pediatria

Volumn 23, Issue 2, 1997, Pages 210-223

  Bavastrelli, M ^a   Sanguigni, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Drug resistance; Malaria; Prophylaxis; Treatment

Indexed keywords

EID: 33748028762     PISSN: 03925161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Longworth DL. Drug-resistant malaria in children and in travellers. Pediatr Clin North Am 1995;42:649-663.
2. Sanguigni S, Marangi M, Cultrera A, Fratto N, De Gregorio CG, Sebastiani A. La malaria di importazione. Un decennio di esperienza. Parass 1988;30:182-183.
3. Sanguigni S, Marangi M, Aceti A, Toccaceli F, Laghi V, Sebastiani A. Imported malaria in Italy, personal experience. In: Proceedings Second Conference on International Travel Medicine. Atlanta 9-12 may, 1991:74.
4. McCaslin RI, Pikis A, Rodriguez WJ. Pediatric Plasmodium falciparum malaria: a ten years experience from Washington, DC. Pediatr Infect Dis J 1994;13:709-715.
5. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop 1994;56:143-156.
6. Krogstad DJ, Schlesinger PH. The basis of antimalarial action non-weak base effects of chloroquine on acid vesicle pH. Am J Trop Med Hyg 1987;36:213-220.
7. Di Perri G, Guasparri Di Perri I, Badona Monteiro G, Bonora S, Hennig C, Cassatella M, Micciolo R, Vento S, Dusi S, Bassetti D, Concia E. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. JID 1995;117:1317-1322.
8. Kyde DE, Oduola AMJ, Martin SK, Milhous WK. Plasmodium falciparum modulation by calcium antagonists of resistance to chloroquine, desethyl-chloroquine, quinine and quinidine in vitro. Trans R Soc Trop Med Hyg 1990;84:474-478.
9. Peters W, Ekong R, Robinson BL, Warhust DC, Pan. The chemotherapy of rodent malaria. XLV. Reversal chloroquine resistance in rodent and human Plasmodium by antihistaminic agents. Ann Trop Med Parasitol 1990;84:541-551.
10. Fogh S, Jepsen S, Effersøe P. Chloroquine resistant P. falciparum strain from Kenya. Trans R Soc Trop Med Hyg 1979;73:228-229.
11. Sanguigni S, De Gregorio CG, Cultrera R, Marangi M. Chloroquine-resistant falciparum malaria from Guinea. Trans R Soc Trop Med Hyg 1988;82:359.
12. Whitby M, Wood G, Veenendaal JR, Rieckmann K. Chloroquine-resistant Plasmodium vivax. Lancet 1989; ii:1395.
13. Collignon FJ. Chloroquine-resistant Plasmodium vivax: it may be a common problem (letter). Med J Aust 1992;157:426.
14. Baird JK, Basri H, Purnomo P, Bangs MJ, Subianto B, Patchen LC, Hoffman SL. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 1991;44:547-552.
15. Schartz JK, Lackritz EM, Patchen LC. Chloroquine-resistant Plasmodium vivax from Indonesia (letter). N Engl J Med 1991;324:927.
16. Canessa A, Mazzarello G, Cruciani M, Bassetti D. Chloroquine-resistant Plasmodium vivax in Brazil (letter). Trans R Soc Med Hyg 1992;86:570.
17. Bjorkman A. Quinine-resistant malaria in Africa (letter). Trans R Soc Med Hyg 1991;85:138.
18. Raccurt CP, Dumestre-Toulet V, Abraham E, Le Bras M, Brachet-Liermain A, Riper C. Failure of P. falciparum malaria prophylaxis by mefloquine in travellers from West Africa. Am J Trop Med Hyg 1991;45:319-324.
19. Karwackij JJ, Kyle Webstern H, Limsomwong N, Shans GD. Two cases of mefloquine resistant malaria in Thailand. Trans R Soc Trop Med Hyg 1989;83:152-153.
20. Brasseur P, Koumaouo J, Moyou-Somo R, Druilhe P. Mefloquine resistant malaria in Cameroon and correlation with resistance to quinine. Mem Inst Oswaldo Cruz 1992;87:271-273.
21. Gay F, Bustos G, Diquet B, Rivero LR, Litaudon M, Pichet C, Danis M, Gentilini M. Cross-resistance between mefloquine and halofantrine. Lancet 1990;ii:1262.
22. Brasseur P, Kouamouo J, Moyou-Somo R, Druilhe P. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. II. Mefloquine resistance confirmed in «vivo» and in «vitro» and its correlation with quinine resistance. Am J Trop Med Hyg 1992;46:8-14.
23. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Na-Bangchang K, Karbwang J, White NJ. Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria. Br J Clin Pharmacol 1991;31:556-559.
24. Sebastiani A, Sanguigni S, Aceti A, Marangi M. La terapia della malaria. Giorn Mal Inf Parass 1991;43:596-613.
25. Aceti A, Bonincontro A, Cametti C, Celestino A, Leri O. Electrical conductivity of human erythrocytes infected with Plasmodium falciparum and its modification following quinine therapy. Trans R Soc Trop Med Hyg 1990;84:671-672.
26. Basco LK, Le Bras J, Gillontin C, Ringwald P, Rabenjarson E, Gimenez F, Bouchaud O, Farinotti R, Colaud JP. Type R1 resistance to halofantrine in West Africa. Trop Med Parasitol 1991;42:413-415.
27. Felix R, Gay F, Lyogoubi A, Bustos MDG, Diquet B, Danis M, Gentilini M. Résistance croisée a la mefloquine et a l'halofantrine lors d'un paludisme a P. falciparum contracté en Sierra Leone. Bull Soc Path Ex 1990;83.43-45.
28. Sanguigni S, Marangi M, Bavastrelli M, Bertucci PG, Cilio CM, Redondi A, Salzano M, Rossi D, Fileti A, Puhl ML. Halofantrine treatment of Plasmodium falciparum malaria. In: Proceedings of the 1st Asia Pacific Travel Health Congress, Hong Kong 4-8 march, 1996:40.
29. Mehra H, Bhasin VK. In vitro gametocytocidal activity of artemisinin and its derivates on Plasmodium falciparum. Jpn J Med Sci Biol 1993,46:37-43.
30. Wernsdorfer WH, Payne D. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther 1991;50:95-121.
31. Bianchini C, Sanguigni S, Marangi M. La malaria. Enciclopedia Medica II Volume di Aggiornamenti (in press.).
32. Fischer PR. Tropical pediatrics. Nutrition-infection. Pediatrics in Review 1993;14:95-99.
33. Sanguigni S, Marangi M, Cancrini G. Aspetti epidemiologici relativi ad un caso di malaria apparentemente autoctono. Parass 1990;32:242-243.
34. Ruoslanti E. Versatile mechanism of cell adhesion. The Harvey Lectures 1990;84:1-17.
35. Miller LH, Good MF, Milon G. Malaria pathogenesis. Science 1994;264:1878-1883.
36. Handunetti SH, David PH, Perera KLR, Mendis KN. Uninfected erythrocytes form «rosettes» around P. falciparum infected erythrocytes. Am J Trop Med Hyg 1989;40:119-127.
37. Batec AW, Taverne J, Playfair JLH. Solubile malarial antigens induce the production of Tumor Necrosis Factor «in vivo». Immunol 1989;66:600-605.
38. Steele RW, Baffoe-Bonnie B. Cerebral malaria in children. Pediatr Infect Dis J 1995;14:281-285.
39. Krishna S, Davis TME, Chan PCY, Wells B, Robson KJH. Ciprofloxacin and malaria. Lancet 1988;i:1231-1232.
40. Sarma PS. Norfloxacin: a new drug in the treatment of falciparum malaria. Ann Int Med 1989;3:336-337.
41. Gordeuk V, Thuma P, Brittenham G, McLaren C, Parry D, Backenstose A, Biemba G, Msiska R, Holmes L, McKinley E, Vargas L, Gilkeson R, Poltera AA. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 1992;327:1473-1477.
42. Taylor TE, Willis BA, Kazembe P, Chisale M, Wirima JJ, Ratsma EY, Molyneux ME. Rapid coma resolution with artemether in Malawian children with cerebral malaria. Lancet 1993,341:661-662.
43. Alin MH, Kihamia CM, Bjorkman A, Bwijo BA, Premji Z; Mtey GJ, Ashton M. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and «in vitro» susceptibility to artemisinin, cloroquine and mefloquine. Am J Trop Med Hyg 1995; 53: 639-645.
44. Karbwang J, Na-Bangchang K, Thanavibul A, Ditta-in M, Harinasutu T. A comparative clinical trial of two different regimens of artemether plus mefloquine in multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:296-298.
45. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzie U, Graninger W. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. JID 1994;169:467-470.
46. Posner GH, Oh CH, Webster HK, Ager AL Jr, Rossan RN. New, antimalarial, tricyclic 1,2,4-trioxanes: evaluations in mice and monkeys. Am J Trop Med Hyg 1994;50:522-26.
47. Titulaer HA, Eling WM, Zuidema J Pharmacokinetic and pharmacodynamic aspects of artelinic acid in rodents J Pharm Pharmacol 1993;45:830-835.
48. Hofheinz W, Burgin H, Gocke E, Jaquet C, Masciadri R, Schmid G, Stohler H, Urwler H. Ro 42-1611 (arteflene), a new effective: chemical structure and biological activity. Trop Med Parasitol 1994;45.261-265.
49. Kroeger A, Mancheno M, Alarcon J, Pessa K. Insecticide-impregnated bed nets for malaria control: varying experiences from Ecuador, Colombia, and Peru concerning acceptability and effectiveness. Am J Trop Med Hyg 1995;53:313-323.
50. Das PK, Das LK, Parida SK, Patra KP, Jambulingam P. Lambdacyhalothrin treated bed nets as an alternative method of malaria control in tribal villages of Koraput District, Orissa State, India. Southeast Asian J Trop Med Public Health 1993;24:513-521.
51. Gozal D, Fadat G, Hengy C. Long-term chloroquine-proguanil malaria prophylaxis in a non immune pediatric population. J Pediatr 1991;118:142-145.
52. Peto TEA, Gilks CF. Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis. Lancet 1986;i:1256-1260.
53. Weiss WR, Oloo AAJ, Johnson A, Koech D, Hoffman SL. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxcycline, and chloroquine plus proguanil. J Infect Dis 1995;171:1569-1575.
54. Anthonioz PH, Corea P, Lauroy J, Bath MD. Association of malaria and pregnancy: data obtained by microscopic examination of 607 placentas. Dakar Med 1979;24:103-111.
55. Randrianjafisamindrakotroka NS, Rakotomamonity JC, Zafisaona G, Rakotoarimanana DR. The value of anatomo-pathologic examination of the placenta in areas of endemic malaria and low socio-cultural levels. Gynecol Obstet Biol Reprod 1994;23:825-828.
56. Boulos M. Clinical features of malarial infection in diagnosis of malaria. Scientific Publication n. 512. Pan American Health Organization. Washington 1990.
57. Darie H, Haba M. Congenital malaria. Med Trop 1992;52:175-178.
58. Akindele JA, Sowunmi A, Abohweyere AE. Congenital malaria in a hyperendemic area: a preliminary study. Ann Trop Paediatr 1993;13:273-276.
59. Romand S, Bourée P, Gelez J, Bader-Meunier B, Bisaro F, Dommergues JP. Paludisme congénital: un cas survenu chez des jumeaux de mère asyntomatique. La Presse Médicale 1994;23:797-800.
60. Williams N. Malaria hideout found in new mothers. Science 1996;272:1416-1417.
61. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin-sulfate A in the human placenta. Science 1996;272:1502-1504.
62. Gazin PP, Compaore MP, Hutin Y, Molez JF. Infection du Placenta par les Plasmodium en zone d'endémie. Les facteurs de risque. Bull Soc Path Exot 1994;87:97-100.
63. Menendez C. Malaria during pregnancy: a priority area of malaria research and control. Parasitol Today 1995;11:178-183.
64. Greenwood AM, Armstrong JR, Byass P, Snow RW, Greenwood BM. Malaria chemoprophylaxis, birth weight and child survival. Trans R Soc Trop Med Hyg 1992;86:483-485.
65. Menendez C, Todd J, Alonso PL, Lulat S, Francis N, Greenwood BM. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. Am J Trop Med Hyg 1994;97:244-248.
66. Greenwood AM, Menendez C, Alonso PL, Jaffar S, Langerock P, Lulat S, Todd J, M'Boge B, Francis N, Greenwood BM. Can malaria chemoprophylaxis be restricted to first pregnancies? Trans R Soc Trop Med Hyg 1994;88:681-682.
67. Mutabingwa TK, Malle LN, Verhave JP, Eling WM, Meuwissen JH, de Geus A. Malaria chemosuppression during pregnancy. IV. Its effects on the newborn's passive malaria immunity. Trop Geogr Med 1993;45:150-156.
68. Guarner P, Branin B. A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas. Bull World Haelth Organ 1994;72:89-99.
69. Bespiatov VF. The malaria prevalence in at-risk group of the native population in Western Africa. 1- Pregnant women. Med-Parazitol 1993;3:6-8.
70. Reuben R. Women and malaria special risk and appropriate control strategy. Soc Sci Med 1993;37:473-476.
71. Meuris S, Piko BB, Eerens P, Vanbellinghen AM, Dramaix M, Hennart P. Gestational-malaria: assessement of its conseguences on fetal growth. Am J Trop Med Hyg 1993;48:603-609.
72. Sturchler D, Berger R, Etlinger H, Fernex M, Matile H, Pink R, Schlumbom V, Just M. Effects of interferons on immune response to a synthetic peptide malaria sporozoite vaccine in non-immune adults. Vaccine 1989;7:457-461.
73. Sturchler D, Zimmer G, Berger R, Etlinger H, Fernex M, Matile H, Just M. Interferon-alfa and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeks. Bull of the World Health Organ 1990;68S:38-41.
74. Patarroyo G, Franco L, Amador R, Murillo LA, Rocha CL, Rojas M, Patarroyo ME. Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1-14 years. Vaccine 1992;10:175-178.
75. Alonso PL, Smith T, Schellenberg JR, Masanja H, Mwankusye S, Urassa H, Bastos de Azevedo I, Chongela J, Kobero S, Menendez C. Randomized trial of efficacy of SPf66 against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1994;344:1175-1181.
76. Trape JF, Rogier C. Efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children (letter). Lancet 1995;345:134-135.
77. Alonso PL, Tanner M, Smith T, Hayes RJ, Schellenberg JA, Lopez MC, Bastos de Azevedo I, Menendez C, Lyimo E, Weiss N. A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design. Vaccine 1994;12:181-186.
78. Valero MV, Amador LR, Galindo C, Figueroa J, Bello MS, Murillo LA, Mora AL, Patarroyo G, Rocha CL, Rojas M, Aponte JJ, Sarmiento LE, Lozada DM, Coronell CG, Ortega NM, Rosas YE, Alonso PL, Patarroyo ME. Vaccination with SPf66, a chemically synthesised vaccine, against Plamodium falciparum in Colombia. Lancet 1993;341:705-710.
79. Allen S, Genton B, Alexander N, Gibson N, Raiko A. Malaria vaccine in children under 12 months of age. Lancet 1995;346:1555-56.
80. Ballou WR, Blood J, Chongsuphajaissidhi T, Gordon DM. Heppner DG, Kyle DE, Luxemburger C, Nosten F, Sadoff JC, Singhasivanon P. Field trials of an asexual blood stage malaria vaccine: studies of the syntetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study. Parasitol 1995;110:S25-36.
81. Sempertegui F, Estrella B, Moscoso J, Piedrahita L, Hernandez D, Gaybor J, Naranjo P, Mancero O, Arias S, Bernal R, Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador. Vaccine 1994;12:337-342.